Individuals who may be at greater risk include: Those with a pre-existing diagnosis of osteoarthritis, rheumatoid arthritis, or other inflammatory joint conditions Patients with obesity-related joint loading, particularly affecting the knees, hips, and lower back Older adults, in whom musculoskeletal complaints are more prevalent at baseline Individuals experiencing rapid weight loss, which may transiently alter joint mechanics and gait, particularly in the lower limbs this is a theoretical consideration based on general musculoskeletal principles rather than retatrutide-specific evidence Significant weight reduction one of retatrutide's primary therapeutic effects is generally associated with reduced mechanical load on weight-bearing joints , which may improve joint symptoms over time in individuals with obesity-related arthropathy
From the chart: 0.5mg was 10 units
On the other hand, Ozempic, a medication primarily used to manage type 2 diabetes and aid weight loss, has its own set of effects on appetite and blood sugar regulation
Heres a quick look at the pros and cons: Pros: Holistic Approach : Combines psychology-based tools with medical interventions for sustainable weight loss
But the FDA has approved weight loss drugs that contain the same active ingredients as Ozempic and Mounjaro